250
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Utility of High-Resolution Accurate Ms to Eliminate Interferences in The Bioanalysis of Ribavirin And Its Phosphate Metabolites

, , &
Pages 1895-1905 | Published online: 03 Sep 2012

References

  • No authors listed. Multicenter clinical trial of oral ribavirin in symptomatic HIV-infected patients. The Ribavirin ARC Study Group. J. Acquir. Immune Defic. Syndr. 6(1), 32–41 (1993).
  • Patki SA , GuptaP. Evaluation of ribavirin in the treatment of acute hepatitis. Chemotherapy28(4), 298–303 (1982).
  • Kumta NB , AntaniDN. Ribavirin trial in cases of infective hepatitis. Indian Pediatr. 20(2), 99–103 (1983).
  • Gerolami R , BorentainP, RaissouniF, MotteA, SolasC, ColsonP. Treatment of severe acute hepatitis E by ribavirin. J. Clin. Virol. 52(1), 60–62 (2011).
  • Martin P , JensenDM. Ribavirin in the treatment of chronic hepatitis C. J. Gastroenterol. Hepatol. 23(6), 844–855 (2008).
  • Fried MW . Side effects of therapy of hepatitis C and their management. Hepatology36(5), S237–S244 (2002).
  • Canonico PG , KastelloMD, SpearsCT, BrownJR, JacksonEA, JenkinsDE. Effects of ribavirin on red blood cells. Toxicol. Appl. Pharmacol. 74(2), 155–162 (1984).
  • Pruvost A , BecherF, BardouillePet al. Direct determination of phosphorylated intracellular anabolites of stavudine (d4T) by liquid chromatography–tandem mass spectrometry. Rapid Commun. Mass Spectrom. 15(16), 1401–1408 (2001).
  • Shou WZ , BuHZ, AddisonT, JiangX, NaidongW. Development and validation of a liquid chromatography–tandem mass spectrometry (LC–MS/MS) method for the determination of ribavirin in human plasma and serum. J. Pharm. Biomed. Anal. 29(1–2), 83–94 (2002).
  • Xing J , ApedoA, TymiakA, ZhaoN. Liquid chromatographic analysis of nucleosides and their mono-, di- and triphosphates using porous graphitic carbon stationary phase coupled with electrospray mass spectrometry. Rapid Commun. Mass Spectrom. 18(14), 1599–1606 (2004).
  • Homma M , JayewardeneAL, GambertoglioJ, AweekaF. High-performance liquid chromatographic determination of ribavirin in whole blood to assess disposition in erythrocytes. Antimicrob. Agents Chemother. 43(11), 2716–2719 (1999).
  • Svensson JO , BruchfeldA, SchvarczR, StahleL. Determination of ribavirin in serum using highly selective solid-phase extraction and high-performance liquid chromatography. Ther. Drug Monit. 22(2), 215–218 (2000).
  • Yeh LT , NguyenM, LourencoD, LinCC. A sensitive and specific method for the determination of total ribavirin in monkey liver by high-performance liquid chromatography with tandem mass spectrometry. J. Pharm. Biomed. Anal. 38(1), 34–40 (2005).
  • Van Der Lijke H , AlffenaarJW, KokWT, GreijdanusB, UgesDR. Determination of ribavirin in human serum using liquid chromatography–tandem mass spectrometry. Talanta88, 385–390 (2012).
  • Bushman LR , KiserJJ, RowerJEet al. Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC–MS/MS detection. J. Pharm. Biomed. Anal. 56(2), 390–401 (2011).
  • Melendez M , RosarioO, ZayasB, RodriguezJF. HPLC–MS/MS method for the intracellular determination of ribavirin monophosphate and ribavirin triphosphate in CEM ss cells. J. Pharm. Biomed. Anal. 49(5), 1233–1240 (2009).
  • Shi G , WuJT, LiYet al. Novel direct detection method for quantitative determination of intracellular nucleoside triphosphates using weak anion exchange liquid chromatography–tandem mass spectrometry. Rapid Commun. Mass Spectrom. 16(11), 1092–1099 (2002).
  • Liu X , VillaltaPW, SturlaSJ. Simultaneous determination of inositol and inositol phosphates in complex biological matrices: quantitative ion-exchange chromatography–tandem mass spectrometry. Rapid Commun. Mass Spectrom. 23(5), 705–712 (2009).
  • Ilett KF , EthellBT, MaggsJLet al. Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases. Drug Metab. Dispos. 30(9), 1005–1012 (2002).
  • Xia YQ , LauJ, OlahT, JemalM. Targeted quantitative bioanalysis in plasma using liquid chromatography–high-resolution accurate mass spectrometry: an evaluation of global selectivity as a function of mass resolving power and extraction window, with comparison of centroid and profile modes. Rapid Commun. Mass Spectrom. 25(19), 2863–2878 (2011).
  • Bateman KP , KellmannM, MuensterH, PappR, TaylorL. Quantitative–qualitative data acquisition using a benchtop Orbitrap mass spectrometer. J. Am. Soc. Mass Spectrom. 20(8), 1441–1450 (2009).
  • Zhang J , MaloneyJ, DrexlerDMet al. Cassette incubation followed by bioanalysis using high-resolution MS for in vitro ADME screening assays. Bioanalysis4(5), 581–593 (2012).
  • Ramanathan R , KorfmacherW. The emergence of high-resolution MS as the premier analytical tool in the pharmaceutical bioanalysis arena. Bioanalysis4(5), 467–469 (2012).
  • Josephs JL . HRMS: current usage, future directions and the promise of integration with unified data streams suited to post-acquisition mining. Bioanalysis4(5), 471–476 (2012).
  • Boyd RK , BasicC, BethemRA. Trace Quantitative Analysis by Mass Spectrometry. John Wiley & Sons Ltd, West Sussex, UK (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.